Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Dermatology Reports
Erschienen in: Current Dermatology Reports 4/2018

12.09.2018 | Wound Care and Healing (H Lev-Tov, Section Editor)

Dress for Success: a Review of Dressings and Wound Care in Hidradenitis Suppurativa

verfasst von: Taylor L. Braunberger, Sakeena Fatima, Gautham Vellaichamy, Amanda F. Nahhas, Angela Parks-Miller, Iltefat H. Hamzavi

Erschienen in: Current Dermatology Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Hidradenitis suppurativa is characterized by lesions and draining sinus tracts in intimate locations. Although often overlooked, the selection of an effective, comfortable dressing can dramatically improve patients’ lives. We aimed to review dressings based on management of post-surgical and non-surgical wound dressings. We reviewed the characteristics and types of dressings used in patients with hidradenitis suppurativa and addressed recommendations for dressing post-surgical and non-surgical wounds.

Recent Findings

Available studies on dressings are few in number with small sample sizes. There were no studies comparing the efficacy of dressings in hidradenitis suppurativa patients. The types of dressings include superabsorbent/absorbent dressings, foam dressings, hydrofiber dressings, alginate dressings, silicone adherent dressings, non-adherent dressings, hydrocolloid dressings, silver-impregnated dressings, iodine-impregnated dressings, and honey-impregnated dressings, and platelet-rich plasma gel and hyaluronic acid scaffold dressings. Providers should consider the “TIME” acronym when assessing post-surgical and non-surgical wounds to select the appropriate dressing.

Summary

As an important component of wound healing, large, randomized controlled trials that compare dressing options for the management of wounds in hidradenitis suppurativa patients are needed.
Literatur
1.
• Gill L, Williams M, Hamzavi I. Update on hidradenitis suppurativa: connecting the tracts. F1000Prime Rep. 2014;6:112. This paper reviewed the important characteristics of hidradenitis suppurativa PubMedPubMedCentral
2.
Jemec GB. Quality of life considerations and pain management in hidradenitis suppurativa. Semin Cutan Med Surg. 2017;36(2):75–8.CrossRef
3.
• Alavi A, Kirsner RS. Local wound care and topical management of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5 Suppl 1):S55–61. This paper reviewed the evidence for treatment of hidradenitis suppurativa wounds CrossRef
4.
Westby MJ, et al. Dressings and topical agents for treating pressure ulcers. Cochrane Database Syst Rev. 2017;6(6):CD011947.PubMed
5.
Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 2004;17(1):59–67.CrossRef
6.
Carville K. Which dressing should I use? It all depends on the ‘TIMEING’. Aust Fam Physician. 2006;35(7):486–9.PubMed
7.
Madan V, Hindle E, Hussain W, August PJ. Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser. Br J Dermatol. 2008;159(6):1309–14.CrossRef
8.
Li HZ, Zhang L, Chen JX, Zheng Y, Zhu XN. Silver-containing dressing for surgical site infection in clean and clean-contaminated operations: a systematic review and meta-analysis of randomized controlled trials. J Surg Res. 2017;215:98–107.CrossRef
9.
Davies P, McCarty S, Hamberg K. Silver-containing foam dressings with Safetac: a review of the scientific and clinical data. J Wound Care. 2017;26(Sup6a):S1–s32.CrossRef
10.
Hazen PG, Hazen BP. Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg. 2010;36(2):208–13.CrossRef
11.
Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol. 2002;47(2):280–5.CrossRef
12.
Fischer M, Gebhard F, Hammer T, Zurek C, Meurer G, Marquardt C, et al. Microbial alginate dressings show improved binding capacity for pathophysiological factors in chronic wounds compared to commercial alginate dressings of marine origin. J Biomater Appl. 2017;31(9):1267–76.CrossRef
13.
Koehler J, Wallmeyer L, Hedtrich S, Goepferich AM, Brandl FP. pH-modulating poly (ethylene glycol)/alginate hydrogel dressings for the treatment of chronic wounds. Macromol Biosci. 2017;17(5):1600369.CrossRef
14.
Blok JL, Spoo JR, Leeman FWJ, Jonkman MF, Horváth B. Skin-tissue-sparing excision with electrosurgical peeling (STEEP): a surgical treatment option for severe hidradenitis suppurativa Hurley stage II/III. J Eur Acad Dermatol Venereol. 2015;29(2):379–82.CrossRef
15.
Liu X, Liu H, Qu X, Lei M, Zhang C, Hong H, et al. Electrical signals triggered controllable formation of calcium-alginate film for wound treatment. J Mater Sci Mater Med. 2017;28(10):146.CrossRef
16.
Alvarez-Suarez JM, et al. The composition and biological activity of honey: a focus on manuka honey. Foods. 2014;3(3):420–32.CrossRef
17.
Cervelli V, Lucarini L, Spallone D, Brinci L, de Angelis B. Use of platelet rich plasma and hyaluronic acid on exposed tendons of the foot and ankle. J Wound Care. 2010;19(5):186, 188-90–90.CrossRef
18.
Cooper RA, et al. Manuka honey used to heal a recalcitrant surgical wound. Eur J Clin Microbiol Infect Dis. 2001;20(10):758–9.CrossRef
19.
West DC, et al. Angiogenesis induced by degradation products of hyaluronic acid. Science. 1985;228(4705):1324–6.CrossRef
20.
Zelen CM, Gould L, Serena TE, Carter MJ, Keller J, Li WW. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers. Int Wound J. 2015;12(6):724–32.CrossRef
21.
• Alavi A, Sibbald RG, Kirsner RS. Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm. J Dermatolog Treat. 2017:1–2. This reference defined an algorithm to assist providers in determining the most appropriate dressing to use for post-surgical and non-surgical wounds in hidradenitis suppurativa patients
22.
Kazemi A, Carnaggio K, Clark M, Shephard C, Okoye GA. Optimal wound care management in hidradenitis suppurativa. J Dermatolog Treat. 2018;29(2):165–7.CrossRef
23.
Skorkowska-Telichowska K, et al. The local treatment and available dressings designed for chronic wounds. J Am Acad Dermatol. 2013;68(4):e117–26.CrossRef
24.
Robinson BJ. The use of a hydrofibre dressing in wound management. J Wound Care. 2000;9(1):32–4.CrossRef
25.
Saco M, et al. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success. Dermatol Online J. 2016;22(8):13030/qt7ph5v17z.PubMed
26.
Dini V, Oranges T, Rotella L, Romanelli M. Hidradenitis suppurativa and wound management. Int J Low Extrem Wounds. 2015;14(3):236–44.CrossRef
27.
van Hattem S, Spoo JR, Horváth B, Jonkman MF, Leeman FWJ. Surgical treatment of sinuses by deroofing in hidradenitis suppurativa. Dermatol Surg. 2012;38(3):494–7.CrossRef
28.
Topley B, Brain S. Hidradenitis suppurativa: a case study. Br J Nurs. 2013;22(15):S16, s18-20–20.CrossRef
29.
Powers JG, Morton LM, Phillips TJ. Dressings for chronic wounds. Dermatol Ther. 2013;26(3):197–206.CrossRef
30.
Dabiri G, Damstetter E, Phillips T. Choosing a wound dressing based on common wound characteristics. Adv Wound Care (New Rochelle). 2016;5(1):32–41.CrossRef
31.
Morgan WP, Harding KG, Richardson G, Hughes LE. The use of silastic foam dressing in the treatment of advanced hidradenitis suppurativa. Br J Surg. 1980;67(4):277–80.CrossRef
32.
Ludolph I, Titel T, Beier JP, Dragu A, Schmitz M, Wullich B, et al. Penile reconstruction with dermal template and vacuum therapy in severe skin and soft tissue defects caused by Fournier’s gangrene and hidradenitis suppurativa. Int Wound J. 2016;13(1):77–81.CrossRef
33.
Jianbing T, Biao C, Qin L, Yanhong W. Topical negative pressure coupled with split-thickness skin grafting for the treatment of hidradenitis suppurativa: a case report. Int Wound J. 2015;12(3):334–7.CrossRef
34.
Mikkelsen PR, Dufour DN, Zarchi K, Jemec GBE. Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study. Dermatol Surg. 2015;41(2):255–60.CrossRef
35.
Maume S, et al. A study to compare a new self-adherent soft silicone dressing with a self-adherent polymer dressing in stage II pressure ulcers. Ostomy Wound Manage. 2003;49(9):44–51.PubMed
36.
Liu HT. Wound care following CO2 laser resurfacing using Kaltostat, Duoderm, and Telfa for dressings. Dermatol Surg. 2000;26(4):341–4.CrossRef
37.
Hollisaz MT, Khedmat H, Yari F. A randomized clinical trial comparing hydrocolloid, phenytoin and simple dressings for the treatment of pressure ulcers [ISRCTN33429693]. BMC Dermatol. 2004;4(1):18.CrossRef
38.
Hessam S, Sand M, Georgas D, Anders A, Bechara FG. Microbial profile and antimicrobial susceptibility of bacteria found in inflammatory hidradenitis suppurativa lesions. Skin Pharmacol Physiol. 2016;29(3):161–7.CrossRef
39.
Ring HC, Thorsen J, Saunte DM, Lilje B, Bay L, Riis PT, et al. The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol. 2017;153(9):897–905.CrossRef
40.
Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem. 1994;31:351–70.CrossRef
41.
Yang B, Wang X, Li Z, Qu Q, Qiu Y. Beneficial effects of silver foam dressing on healing of wounds with ulcers and infection control of burn patients. Pak J Med Sci. 2015;31(6):1334–9.CrossRef
42.
Glat PM, Zhang SH, Burkey BA, Davis WJ. Clinical evaluation of a silver impregnated foam dressing in paediatric partial-thickness burns. J Wound Care. 2015;24(4):S4, s6-10–S10.CrossRef
43.
Gonzaga TA, Endorf FW, Mohr WJ, Ahrenholz DH. Novel surgical approach for axillary hidradenitis suppurativa using a bilayer dermal regeneration template: a retrospective case study. J Burn Care Res. 2013;34(1):51–7.CrossRef
44.
Totty JP, Bua N, Smith GE, Harwood AE, Carradice D, Wallace T, et al. Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review. J Wound Care. 2017;26(3):107–14.CrossRef
45.
Cutting K, McGuire J. Safe, long-term management of bioburden that helps promote healing evidence review of DACC technology. J Wound Care. 2015;24(5 Suppl):S3–5.CrossRef
46.
Skinner R, Hampton S. The diabetic foot: managing infection using Cutimed Sorbact dressings. Br J Nurs. 2010;19(11):S30. s32-6PubMed
47.
Cooper R, Jenkins L. Binding of two bacterial biofilms to dialkyl carbamoyl chloride (DACC)-coated dressings in vitro. J Wound Care. 2016;25(2):76, 78-82–82.CrossRef
48.
Kammerlander G, et al. An investigation of Cutimed® Sorbact® as an antimicrobial alternative in wound management. WOUNDS UK. 2008;4(2):10.
49.
Choi JS, Lee JH, Kim SM, Kim YJ, Choi JY, Jun YJ. Hydrogel-impregnated dressings for graft fixation: a case series. J Wound Care. 2015;24(7):326–8.CrossRef
50.
Murphy PS, Evans GR. Advances in wound healing: a review of current wound healing products. Plast Surg Int. 2012;2012:190436.PubMedPubMedCentral
51.
van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63(3):475–80.CrossRef
52.
Nicoli F, Balzani A, Lazzeri D, Gentile P, Chilgar RM, di Pasquali C, et al. Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix. Int Wound J. 2015;12(3):338–43.CrossRef
53.
Griffiths M, Ojeh N, Livingstone R, Price R, Navsaria H. Survival of Apligraf in acute human wounds. Tissue Eng. 2004;10(7–8):1180–95.CrossRef
54.
Greer N, Foman NA, MacDonald R, Dorrian J, Fitzgerald P, Rutks I, et al. Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review. Ann Intern Med. 2013;159(8):532–42.CrossRef
55.
Towler MA, Rush EW, Richardson MK, Williams CL. Randomized, prospective, blinded-enrollment, head-to-head venous leg ulcer healing trial comparing living, bioengineered skin graft substitute (Apligraf) with living, cryopreserved, human skin allograft (TheraSkin). Clin Podiatr Med Surg. 2018;35(3):357–65.CrossRef
56.
Martinson M, Martinson N. A comparative analysis of skin substitutes used in the management of diabetic foot ulcers. J Wound Care. 2016;25(Sup10):S8–s17.CrossRef
57.
Zelen CM, Orgill DP, Serena T, Galiano R, Carter MJ, DiDomenico LA, et al. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers. Int Wound J. 2017;14(2):307–15.CrossRef
58.
Walters J, et al. Healing rates in a multicenter assessment of a sterile, room temperature, acellular dermal matrix versus conventional care wound management and an active comparator in the treatment of full-thickness diabetic foot ulcers. Eplasty. 2016;16:e10.PubMedPubMedCentral
59.
Reyzelman A, Crews RT, Moore JC, Moore L, Mukker JS, Offutt S, et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J. 2009;6(3):196–208.CrossRef
60.
Schultz, G., A comprehensive biofilm-based management approach.
61.
Schultz, G.S., et al., Wound bed preparation: a systematic approach to wound management. Wound Repair Regen, 2003.11 Suppl 1(Suppl 1): p. S1–28.CrossRef
62.
Leaper, D.J., et al., Extending the TIME concept: what have we learned in the past 10 years?(*). Int Wound J, 2012.9 Suppl 2(Suppl 2): p. 1–19.CrossRef
63.
Halim AS, Khoo TL, Saad AZ. Wound bed preparation from a clinical perspective. Indian J Plast Surg. 2012;45(2):193–202.CrossRef
64.
65.
Leaper DJ, Schultz G, Carville K, Fletcher J, Swanson T, Drake R. Extending the TIME concept: what have we learned in the past 10 years?(*). Int Wound J. 2012;9(Suppl 2):1–19.CrossRef
66.
Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11(Suppl 1):S1–28.CrossRef
67.
Deutsch CJ, Edwards DM, Myers S. Wound dressings. Br J Hosp Med (Lond). 2017;78(7):C103–c109.CrossRef
68.
Broussard KC, Powers JG. Wound dressings: selecting the most appropriate type. Am J Clin Dermatol. 2013;14(6):449–59.CrossRef
69.
Saco M, et al. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success. Dermatol Online J. 2016:22(8).
70.
Ursani MA, Appleyard J, Whiteru O. Pyogenic arthritis, pyoderma gangrenosum, acne, suppurative hidradenitis (PA-PASH) syndrome: an atypical presentation of a rare syndrome. Am J Case Rep. 2016;17:587–91.CrossRef
71.
Sonbol H, Duchatelet S, Miskinyte S, Bonsang B, Hovnanian A, Misery L. PASH syndrome (pyoderma gangrenosum, acne and hidradenitis suppurativa): a disease with genetic heterogeneity. Br J Dermatol. 2018;178(1):e17–8.CrossRef
72.
Hsiao JL, Antaya RJ, Berger T, Maurer T, Shinkai K, Leslie KS. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol. 2010;146(11):1265–70.CrossRef
73.
Ratnagobal S, Sinha S. Pyoderma gangrenosum: guideline for wound practitioners. J Wound Care. 2013;22(2):68–73.CrossRef
74.
Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13(3):191–211.CrossRef
Metadaten
Titel
Dress for Success: a Review of Dressings and Wound Care in Hidradenitis Suppurativa
verfasst von
Taylor L. Braunberger
Sakeena Fatima
Gautham Vellaichamy
Amanda F. Nahhas
Angela Parks-Miller
Iltefat H. Hamzavi
Publikationsdatum
12.09.2018
Verlag
Springer US
Erschienen in
Current Dermatology Reports / Ausgabe 4/2018
Elektronische ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-018-0231-z

Weitere Artikel der Ausgabe 4/2018

Current Dermatology Reports 4/2018 Zur Ausgabe

Wound Care and Healing (H Lev-Tov, Section Editor)

Use of Lasers in Wound Healing: How to Best Utilize Laser Technology to Prevent Scar Formation

Invited Commentary

Complementary and Alternative Methods for Treatment of Acne Vulgaris: a Systematic Review

Atopic Dermatitis (C Vestergaard, Section Editor)

The Skin Microbiome in Atopic Dermatitis—a Potential Treatment Target?

IImmunology (D Lee, Section Editor)

Epidemiology and Immunopathogenesis of Psoriasis and Its Comorbidities

Atopic Dermatitis (C Vestergaard, Section Editor)

Skin Barrier Function and Atopic Dermatitis

Immunology (D Lee, Section Editor)

Immune and Inflammatory Reponses to Staphylococcus aureus Skin Infections

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

12.04.2024 | Vitiligo | Nachrichten

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

12.04.2024 | Atopische Dermatitis | Nachrichten

Dupilumab ist mit kutanen T-Zell-Lymphomen assoziiert

09.04.2024 | DGP 2024 | Kongressbericht | Nachrichten

Chemotherapie mit Hindernissen
weitere anzeigen

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise